Therapeutic vaccination using HPV 16 E7 to eradicate CIN3

Affiliations

Editorial

Krishnansu S Tewari. J Gynecol Oncol. 2019 Nov.

. 2019 Nov;30(6):e119.

doi: 10.3802/jgo.2019.30.e119.

¹ Division of Gynecologic Oncology, University of California, Irvine Medical Center, Irvine, CA, USA. ktewari@uci.edu.

No abstract available

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.
Park YC, Ouh YT, Sung MH, Park HG, Kim TJ, Cho CH, Park JS, Lee JK. Park YC, et al. J Gynecol Oncol. 2019 Nov;30(6):e88. doi: 10.3802/jgo.2019.30.e88. J Gynecol Oncol. 2019. PMID: 31576684 Free PMC article. Clinical Trial.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
1. Tewari KS, Monk BJ. Evidence-based treatment paradigms for management of invasive cervical carcinoma. J Clin Oncol. 2019 - PMC - PubMed
1. Tewari KS, Sill MW, Long HJ, 3rd, Penson RT, Huang H, Ramondetta LM, et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014;370:734–743. - PMC - PubMed
1. Karamperopoulos D, Kouzis A. Cancer in ancient Greek physicians. Athens: Stamoulis; 1902.
1. Rigoni-Stern DA. Statistical facts related to cancerous diseases. G Serv Progress Patologia Terapia. 1842;2:507–517.